➔ Preventive ongoing measures ➔ | In asplenic patients vaccinated with pneumococcal vaccines | In asplenic patients vaccinated with HIB vaccine | In asplenic patients vaccinated with annual influenza vaccine | In asplenic patients vaccinated with Neisseria meningitidis vaccines (all serogroups) | In asplenic patients receiving antibiotic prophylaxis ≥2 years | ||
---|---|---|---|---|---|---|---|
with PCV13 only | with PPSV23 only | with PCV13+PPSV23 | |||||
Number of infections (lung and/or ENT and/or influenza) (N = 31) | 2 | 9 | 16 | 22 | 21 | 14 | 18 |